Related Experiment Videos
[Initial therapeutic experiences in AIDS in childhood]
1Infektionsabteilung des Landes-Kinderkrankenhauses Linz.
Padiatrie Und Padologie
|January 1, 1990
Summary
Pediatric acquired immuno-deficiency syndrome (AIDS) presents diagnostic challenges. This study details three children with HIV, exploring their classification, treatment with prednisolone, and prophylactic use of cotrimoxazole and immunoglobulin therapy.
Area of Science:
- Pediatrics
- Infectious Diseases
- Immunology
Background:
- Pediatric acquired immuno-deficiency syndrome (AIDS) diagnosis and treatment pose significant challenges.
- Classification follows the CDC's recommendations for pediatric HIV infection.
- Maternal HIV transmission is a key concern, with intravenous drug use being a risk factor.
Observation:
- Three children born to HIV-positive mothers were studied.
- One child (S.M.) classified P2-AB and two (K.C., D.M.) with lymphoid interstitial pneumonia (P2-C) were observed.
- Patient D.M. showed remarkable pulmonary improvement after prednisolone treatment.
Findings:
- All patients received oral antimycotics and prophylactic cotrimoxazole for Pneumocystis pneumonia.
- Parenteral immunoglobulin therapy was initiated to prevent secondary infections, with a dosage of 0.4 g/kg monthly.
- Positive outcomes from international experiences informed the use of immunoglobulin therapy.
Implications:
- Early diagnosis and classification are crucial for managing pediatric AIDS.
- Multifaceted treatment approaches, including corticosteroids and prophylactic antimicrobials, are vital.
- Immunoglobulin therapy shows promise in reducing infection rates in immunocompromised children with HIV.